Neuro-ophthalmology drug pipelines

Roche

RG6168

Neuromyelitis optica

Phase III


GlaxoSmithKline

933776

geographic retinal atrophy

beta amyloid monoclonal antibody

Phase II


Biogen

XLRS Gene Therapy

X-linked retinoschisis

gene therapy

Phase II


Shire

SHP-616

Neuromyelitis Optica (acute)

Phase I


Quark

QPI-1007

Non-Arteritic Anterior Ischemic Optic Neuropathy

synthetic siRNA

Phase I